MEIP
Price
$6.74
Change
-$0.15 (-2.18%)
Updated
Oct 4, 6:59 PM EST
MRTX
Price
$42.89
Change
-$0.76 (-1.74%)
Updated
Oct 4, 6:59 PM EST
34 days until earnings call

Analysis and predictions MEIP vs MRTX

Header iconMEIP vs MRTX Comparison
Open Charts MEIP vs MRTXBanner chart's image
MEI Pharma
Price$6.74
Change-$0.15 (-2.18%)
Volume$60.19K
CapitalizationN/A
Mirati Therapeutics
Price$42.89
Change-$0.76 (-1.74%)
Volume$436.98K
CapitalizationN/A
View a ticker or compare two or three
MEIP vs MRTX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
MEIP vs. MRTX commentary
Oct 05, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEIP is a Hold and MRTX is a StrongBuy.

COMPARISON
Comparison
Oct 05, 2023
Stock price -- (MEIP: $6.89 vs. MRTX: $43.65)
Brand notoriety: MEIP and MRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MEIP: 105% vs. MRTX: 84%
Market capitalization -- MEIP: $46.51M vs. MRTX: $2.93B
MEIP [@Biotechnology] is valued at $46.51M. MRTX’s [@Biotechnology] market capitalization is $2.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $403.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEIP’s FA Score shows that 0 FA rating(s) are green whileMRTX’s FA Score has 0 green FA rating(s).

  • MEIP’s FA Score: 0 green, 5 red.
  • MRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MRTX is a better buy in the long-term than MEIP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MEIP’s TA Score shows that 5 TA indicator(s) are bullish while MRTX’s TA Score has 5 bullish TA indicator(s).

  • MEIP’s TA Score: 5 bullish, 5 bearish.
  • MRTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both MEIP and MRTX are a good buy in the short-term.

Price Growth

MEIP (@Biotechnology) experienced а -6.13% price change this week, while MRTX (@Biotechnology) price change was +7.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.90%. For the same industry, the average monthly price growth was +16.30%, and the average quarterly price growth was +20.78%.

Reported Earning Dates

MEIP is expected to report earnings on Aug 31, 2023.

MRTX is expected to report earnings on Nov 07, 2023.

Industries' Descriptions

@Biotechnology (-2.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MEIP with price predictions.
OPEN
A.I.dvisor published
a Summary for MRTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MRTX($2.94B) has a higher market cap than MEIP($46.5M). MEIP YTD gains are higher at: 41.420 vs. MRTX (-3.664). MEIP has higher annual earnings (EBITDA): -41.51M vs. MRTX (-775.47M). MRTX has more cash in the bank: 779M vs. MEIP (112M). MEIP has less debt than MRTX: MEIP (13.1M) vs MRTX (50.7M). MEIP has higher revenues than MRTX: MEIP (58.8M) vs MRTX (27.2M).
MEIPMRTXMEIP / MRTX
Capitalization46.5M2.94B2%
EBITDA-41.51M-775.47M5%
Gain YTD41.420-3.664-1,131%
P/E RatioN/AN/A-
Revenue58.8M27.2M216%
Total Cash112M779M14%
Total Debt13.1M50.7M26%
FUNDAMENTALS RATINGS
MEIP vs MRTX: Fundamental Ratings
MEIP
MRTX
OUTLOOK RATING
1..100
8317
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
3745
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRTX's Valuation (60) in the Biotechnology industry is in the same range as MEIP (81) in the Pharmaceuticals Other industry. This means that MRTX’s stock grew similarly to MEIP’s over the last 12 months.

MRTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MEIP (100) in the Pharmaceuticals Other industry. This means that MRTX’s stock grew similarly to MEIP’s over the last 12 months.

MRTX's SMR Rating (98) in the Biotechnology industry is in the same range as MEIP (98) in the Pharmaceuticals Other industry. This means that MRTX’s stock grew similarly to MEIP’s over the last 12 months.

MEIP's Price Growth Rating (37) in the Pharmaceuticals Other industry is in the same range as MRTX (45) in the Biotechnology industry. This means that MEIP’s stock grew similarly to MRTX’s over the last 12 months.

MEIP's P/E Growth Rating (96) in the Pharmaceuticals Other industry is in the same range as MRTX (100) in the Biotechnology industry. This means that MEIP’s stock grew similarly to MRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MEIPMRTX
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SATX0.56N/A
+0.81%
SatixFy Communications Ltd
PAAS13.740.04
+0.29%
Pan American Silver Corp
SMMT1.77N/A
+0.28%
Summit Therapeutics
AMGN261.04-5.27
-1.98%
Amgen
IONR5.69-0.12
-2.07%
ioneer Ltd

MEIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEIP has been loosely correlated with ICVX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MEIP jumps, then ICVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEIP
1D Price
Change %
MEIP100%
-1.29%
ICVX - MEIP
51%
Loosely correlated
-1.50%
GOSS - MEIP
43%
Loosely correlated
-6.04%
MRTX - MEIP
31%
Poorly correlated
+3.95%
AVXL - MEIP
28%
Poorly correlated
-1.73%
AXON - MEIP
28%
Poorly correlated
-2.09%
More

MRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if MRTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRTX
1D Price
Change %
MRTX100%
+3.95%
MDGL - MRTX
43%
Loosely correlated
-1.59%
VOR - MRTX
40%
Loosely correlated
+5.63%
CDMO - MRTX
40%
Loosely correlated
+4.03%
SNDX - MRTX
39%
Loosely correlated
-6.52%
AVXL - MRTX
38%
Loosely correlated
-1.73%
More